» Articles » PMID: 16551255

How TCRs Bind MHCs, Peptides, and Coreceptors

Overview
Date 2006 Mar 23
PMID 16551255
Citations 652
Authors
Affiliations
Soon will be listed here.
Abstract

Since the first crystal structure determinations of alphabeta T cell receptors (TCRs) bound to class I MHC-peptide (pMHC) antigens in 1996, a sizable database of 24 class I and class II TCR/pMHC complexes has been accumulated that now defines a substantial degree of structural variability in TCR/pMHC recognition. Recent determination of free and bound gammadelta TCR structures has enabled comparisons of the modes of antigen recognition by alphabeta and gammadelta T cells and antibodies. Crystal structures of TCR accessory (CD4, CD8) and coreceptor molecules (CD3epsilondelta, CD3epsilongamma) have further advanced our structural understanding of most of the components that constitute the TCR signaling complex. Despite all these efforts, the structural basis for MHC restriction and signaling remains elusive as no structural features that define a common binding mode or signaling mechanism have yet been gleaned from the current set of TCR/pMHC complexes. Notwithstanding, the impressive array of self, foreign (microbial), and autoimmune TCR complexes have uncovered the diverse ways in which antigens can be specifically recognized by TCRs.

Citing Articles

Feature selection enhances peptide binding predictions for TCR-specific interactions.

Teimouri H, Ghoreyshi Z, Kolomeisky A, George J Front Immunol. 2025; 15:1510435.

PMID: 39916960 PMC: 11799297. DOI: 10.3389/fimmu.2024.1510435.


Leveraging mRNA technology for antigen based immuno-oncology therapies.

Floudas C, Sarkizova S, Ceccarelli M, Zheng W J Immunother Cancer. 2025; 13(1).

PMID: 39848687 PMC: 11784169. DOI: 10.1136/jitc-2024-010569.


Dynamic allostery in the peptide/MHC complex enables TCR neoantigen selectivity.

Ma J, Ayres C, Brambley C, Chandran S, Rosales T, Perera W Nat Commun. 2025; 16(1):849.

PMID: 39833157 PMC: 11756396. DOI: 10.1038/s41467-025-56004-8.


Identification of novel KRAS neoantigen specific TCRs and a strategy to eliminate off-target recognition.

Han X, Han X, Hao Y, Wang B, Li L, Chen S J Transl Med. 2025; 23(1):78.

PMID: 39819441 PMC: 11740425. DOI: 10.1186/s12967-025-06094-1.


Transferrin Disassociates TCR from CD3 Signaling Apparatus to Promote Metastasis.

Cheng R, Tang X, Zhao Q, Wang Y, Chen W, Wang G Research (Wash D C). 2025; 8():0578.

PMID: 39810853 PMC: 11731779. DOI: 10.34133/research.0578.